ahlam1399
06-02-2015, 08:43 PM
FDA panel to discuss Lilly?s lung cancer drug approval
(Reuters) - The U.S. Food and Drug Administration said a panel of experts would discuss a marketing application from Eli Lilly & Co on a new targeted lung cancer treatment.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46ddc792/sc/21/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=cVtmTSt-p7s:-3TnxRw70ow:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cVtmTSt-p7s:-3TnxRw70ow:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=cVtmTSt-p7s:-3TnxRw70ow:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cVtmTSt-p7s:-3TnxRw70ow:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=cVtmTSt-p7s:-3TnxRw70ow:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/cVtmTSt-p7s
(Reuters) - The U.S. Food and Drug Administration said a panel of experts would discuss a marketing application from Eli Lilly & Co on a new targeted lung cancer treatment.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46ddc792/sc/21/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=cVtmTSt-p7s:-3TnxRw70ow:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cVtmTSt-p7s:-3TnxRw70ow:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=cVtmTSt-p7s:-3TnxRw70ow:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cVtmTSt-p7s:-3TnxRw70ow:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=cVtmTSt-p7s:-3TnxRw70ow:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/cVtmTSt-p7s